Recro Pharma, Inc. Insider Trading for October 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for October 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Myers Diane | Director | Payment of Exercise | F | 9.04 | 2,480 | 22,419 | 8,803 | 11.3 K to 8.8 K (-21.98 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Myers Diane | Director | Buy | M | 0.00 | 8,000 | 0 | 11,283 | 3.3 K to 11.3 K (+243.68 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Payment of Exercise | F | 9.04 | 4,649 | 42,027 | 11,601 | 16.3 K to 11.6 K (-28.61 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Buy | M | 0.00 | 15,000 | 0 | 16,250 | 1.3 K to 16.3 K (+1,200.00 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Mack Randall | Senior VP, Developm ... | Payment of Exercise | F | 9.04 | 4,649 | 42,027 | 20,113 | 24.8 K to 20.1 K (-18.77 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Mack Randall | Senior VP, Developm ... | Buy | M | 0.00 | 15,000 | 0 | 24,762 | 9.8 K to 24.8 K (+153.66 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 9.04 | 9,794 | 88,538 | 125,806 | 135.6 K to 125.8 K (-7.22 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Buy | M | 0.00 | 31,100 | 0 | 135,600 | 104.5 K to 135.6 K (+29.76 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Payment of Exercise | F | 9.04 | 1,905 | 17,221 | 4,095 | 6 K to 4.1 K (-31.75 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Buy | M | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Buy | M | 0.00 | 2,000 | 0 | 10,000 | 8 K to 10 K (+25.00 %) |